Skip to main content
Sean Dineen, MD, General Surgery, Tampa, FL, H. Lee Moffitt Cancer Center and Research Institute

SeanPatrickDineenMD

General Surgery Tampa, FL

Surgical Oncology (Other than Breast)

Associate Member Gastrointestinal Oncology, Associate Professor Morsani College of Medicine

Overview of Dr. Dineen

Dr. Sean Dineen is a general surgeon in Tampa, FL and is affiliated with H. Lee Moffitt Cancer Center and Research Institute. He received his medical degree from University of Louisville School of Medicine and has been in practice 14 years. He is one of 66 doctors at H. Lee Moffitt Cancer Center and Research Institute who specialize in General Surgery. He has more than 80 publications and over 500 citings.

Education & Training

  • University of Texas M D Anderson Cancer Center
    University of Texas M D Anderson Cancer CenterFellowship, Complex General Surgical Oncology, 2013 - 2015
  • Emory University School of Medicine
    Emory University School of MedicineFellowship, Thoracic Surgery, 2010 - 2011
  • University of Texas Southwestern Medical Center
    University of Texas Southwestern Medical CenterResidency, Surgery, 2003 - 2010
  • University of Louisville School of Medicine
    University of Louisville School of MedicineClass of 2003

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2017 - 2024
  • KY State Medical License
    KY State Medical License 2015 - 2018
  • TX State Medical License
    TX State Medical License 2007 - 2017
  • American Board of Surgery Surgery
  • American Board of Surgery Complex General Surgical Oncology

Awards, Honors, & Recognition

  • Medical Student Teaching Honors USF Morsani College of Medicine, 2020
  • Spirit of Moffitt Award Moffitt Cancer Center, 2019
  • Traveling Observer-ship European Society of Surgical Oncology, 2017
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Synthetic Molecules May Be Less Expensive Alternative to Therapeutic Antibodies
    Synthetic Molecules May Be Less Expensive Alternative to Therapeutic AntibodiesFebruary 12th, 2016
  • Mesothelioma Surgery with Organ Removal Extends Survival
    Mesothelioma Surgery with Organ Removal Extends SurvivalNovember 18th, 2020

Grant Support

  • Impact of Diagnostic Laparoscopy on Early Identification of Peritoneal Disease in Patients with CRC demonstrating high risk features.Peter and Carmen Lucia Buck Clinical and Translational Research Award2016–2017
  • Targeting Axl-kinase to improve treatment for pancreatic cancerDallas VA Research Corporation (DVARC)2012–2013
  • VEGF as a survival and invasive factor in metastatic breast cancerSusan G. Komen Foundation2006–2008

Committees

  • Member, Residency Evaluation Committee 2015 - 2017
  • Member, Rotation Site Director Committee 2011 - 2013

Professional Memberships

  • Association of Academic Surgeons
    Member
  • Fellow
  • Society for Surgery of the Alimentary Tract (SSAT) Postgraduate Education Committee
    Member
  • SSAT Program Committee; Pancreas Subcommittee
    Member
  • AHPBA Clinical Trials Subcommittee
    Member
  • Florida Chapter of the American College of Surgeons Education Committee
    Member
  • Society of Surgical Oncology Program Directors Committee
    Member
  • Society of Surgical Oncology Peritoneal Surface Malignancy Disease Site Work Group
    Member
  • Society of Surgical Oncology (SSO) 2020 CGSO Board Review Course Planning Committee
    Member
  • Society for Surgery of the Alimentary Tract
    Member
  • Tampa Bay Surgical Oncology Society
    Member

Hospital Affiliations